A Phase 1, Randomized, Open-Label, Single Dose, Two Sequence, Crossover, Relative Bioavailability and Taste Test Study of ATI-1501 in Healthy Adult Volunteers
Phase of Trial: Phase I
Latest Information Update: 18 Jan 2019
At a glance
- Drugs Metronidazole (Primary)
- Indications Clostridium difficile infections
- Focus Pharmacokinetics
- Sponsors Appili Therapeutics
- 10 Jan 2019 Status changed from recruiting to completed.
- 08 Jan 2018 Planned End Date changed from 8 Dec 2017 to 30 Jan 2017.
- 15 Nov 2017 New trial record